Pricing Log in Create free account

Bluejay Diagnostics, Inc. (BJDX) vs Nexalin Technology, Inc. (NXL)

Bluejay Diagnostics, Inc. and Nexalin Technology, Inc. are both Medical Devices companies. Bluejay Diagnostics, Inc. is the larger, with a market value of $2.6M against $1.7M — 1.6× the size. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −4,138.5%) and the higher return on invested capital (0.00% vs −1,108.8%). Across the 13 metrics below, Bluejay Diagnostics, Inc. leads on 11 and Nexalin Technology, Inc. on 2.

Valuation

Metric BJDX NXL Medical Devices median
P/E n/m n/m 24.94
P/S n/m 4.77 2.66
P/B 0.52 0.68 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales n/m 0.16 2.76
Earnings yield (368.94%) (980.57%) (12.66%)
Free cash flow yield (127.64%) (612.33%) (7.18%)

Profitability

Metric BJDX NXL Medical Devices median
Gross margin 0.00% 86.14% 57.76%
Operating margin 0.00% (4,201.66%) (14.84%)
Net margin 0.00% (4,138.49%) (14.45%)
Free cash flow margin 0.00% (2,917.96%) (5.70%)
Return on equity (98.89%) (240.25%) (10.56%)
Return on assets (81.07%) (187.89%) (17.26%)
Return on invested capital 0.00% (1,108.82%) (5.22%)

Growth

Metric BJDX NXL Medical Devices median
Revenue growth (TTM) — 24.26% 10.41%
EPS growth (last fiscal year) 96.66% 39.76% 28.17%
Revenue growth, 5-year CAGR — 4.42% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BJDX NXL Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 4.64 1.25 2.67
Net debt to EBITDA 0.76 0.44 0.54

Dividend

Metric BJDX NXL Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric BJDX NXL Medical Devices median
Market cap 2.62m 1.69m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack